Trump's Push for the World's Lowest Drug Prices Hits Snag With Mid-sized Companies

Published Date: 01 Jul 2026

President Donald Trump has promised to make U.S. prescription drug prices the cheapest in the world, but a closely watched Medicaid pilot program could expose the limits of...

Read Full News

Latest News

Bladder Issues Linger in Kids Treated for Ureter Swelling

Many children surgically treated for a swelling at the end of the ureter have lasting bladder symptoms, such as holding urine or trouble passing stools.

Practical Implications of Targeted Therapies in mHSPC Care

Practical Implications of Targeted Therapies in mHSPC Care

Precision Oncology in mHSPC: Translating Emerging Evidence Into Clinical Practice

Precision Oncology in mHSPC: Translating Emerging Evidence Into Clinical Practice

Clinical Data and Expert Perspectives on Emerging Bispecific ADCs in Urothelial Carcinoma

Clinical Data and Expert Perspectives on Emerging Bispecific ADCs in Urothelial Carcinoma

Mastering Evolving Evidence on Systemic Immunotherapy in the Management of BCG-Naïve, High-Risk NMIBC

Mastering Evolving Evidence on Systemic Immunotherapy in the Management of BCG-Naïve, High-Risk NMIBC

Beyond BCG Alone: Clinical Pearls for Integrating Immunotherapy Earlier in High-Risk NMIBC

Beyond BCG Alone: Clinical Pearls for Integrating Immunotherapy Earlier in High-Risk NMIBC

Todays Updates

Sevabertinib Approved for First-Line Mutated NSCLC

The oral HER2 TKI was previously given accelerated approval in the second line for the indication.

Todays Updates

Sevabertinib Approved for First-Line Mutated NSCLC

The oral HER2 TKI was previously given accelerated approval in the second line for the indication.

Latest News

Many children surgically treated for a swelling at the end of the ureter have lasting bladder symptoms, such as holding urine or trouble passing stools.

Practical Implications of Targeted Therapies in mHSPC Care

Precision Oncology in mHSPC: Translating Emerging Evidence Into Clinical Practice

Clinical Data and Expert Perspectives on Emerging Bispecific ADCs in Urothelial Carcinoma

Mastering Evolving Evidence on Systemic Immunotherapy in the Management of BCG-Naïve, High-Risk NMIBC

Beyond BCG Alone: Clinical Pearls for Integrating Immunotherapy Earlier in High-Risk NMIBC

News All Time

Towards Personalized Treatment in mHSPC: Latest Evidence for Biomarker-Targeted Therapies and Multidisciplinary Toxicity Management

Towards Personalized Treatment in mHSPC: Latest Evidence for Biomarker-Targeted Therapies and Multidisciplinary Toxicity Management

Shaping the Future of Muscle-Invasive Bladder Cancer Treatment With the Integration of Immunotherapy and Multidisciplinary Care

Shaping the Future of Muscle-Invasive Bladder Cancer Treatment With the Integration of Immunotherapy and Multidisciplinary Care

Advancing mHSPC Management: From Clinical Guidelines to Emerging Biomarker-Directed Therapies

Advancing mHSPC Management: From Clinical Guidelines to Emerging Biomarker-Directed Therapies

Optimizing mHSPC Care: Integrating Novel Combination Therapies and the Strategies for Multidisciplinary Management

Optimizing mHSPC Care: Integrating Novel Combination Therapies and the Strategies for Multidisciplinary Management

Personalized Decision-Making for Patients With Advanced HSPC

Personalized Decision-Making for Patients With Advanced HSPC

Half of Patients With Post-BCG Bladder Cancer Achieve CR With Nonviral Gene Therapy

Detalimogene voraplasmid lead to numerous durable complete responses with favorable safety

Durvalumab Plus BCG Cut Early Recurrence of High-Risk Bladder Cancer

POTOMAC data support a year's worth of immuontherapy paired with BCG induction and maintenance

Too Much or Too Little Opioid Pain Relief May Drive Refills After Urologic Surgery

Discharge prescription mismatch versus inpatient dose significantly increased refill rate

Low-Intensity Ultrasound Shatters Kidney Stones in 70% of SOUND Trial Patients

Non-invasive, no-anesthesia lithotripsy recently gained FDA approval

Major Complete Response Rate in Very High-Risk Bladder Cancer With Combo Treatment

Only three of 37 patients did not achieve CR at 6 months with pembrolizumab and BCG

Temporary Prostatic Urethra Expander for BPH/LUTS Shows Durable Results

Study showed immediate improvement in symptoms after intentional retrieval of device at 6 months

He Inserted a Cable in His Penis. 10 Years Later, He Needed Surgery.

Patient in his 60s eventually developed sepsis

Evidence Mounts for Darolutamide Plus ADT in Hormone-Sensitive Prostate Cancer

U.S. study supports findings from a global trial using an external control arm

Erectile Dysfunction May Predispose Older Men to Multiple Types of Substance Abuse

Significantly higher risk of sedative, opioid, cocaine abuse compared with no ED diagnosis

GLP-1 Drugs Linked to Significant Boost in Testosterone Levels for Men

Weight loss likely not the only reason for improvement, researcher says

Tibial Nerve Stimulation for Overactive Bladder Tied to Better Quality of Life

But main results from sham-controlled trial still outstanding

Recommended News For You

Study Supports More Inclusive Clinical Trials With Broader Eligibility Criteria

'Sleep ALL night' program helps children with leukemia sleep better during treatment

Analysis of projected cancer rates in Canada by 2024.

Alarm Over Pharma-China Link; Taking Screening to the People; Agriculture and Cancer

Simpler Screening Criteria Could Catch More Lung Cancers

La FDA ha approvato Talzenna per trattare il cancro alla prostata metastatico che non è resistente alla castrazione.

Chiauranib Slows Platinum-Resistant Ovarian Cancer

Recommended Articles For You

Unlocking the Secrets of Neutrophils: Exploring Their Role in Immune Defense 

Precision to Personalization: Expanding Genetic Testing and Counseling in Oncology 

Spatial Mapping of Tumor Cell States: Integrating Biology, Technology, and Clinical Practice 

The Essential Roadmap for Nutritional Excellence in Head and Neck Cancer Care 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Chromatin organization linked to p53 tumor suppression mechanism

2.

Despite Medicare Coverage, Cancer Genomic Testing Still Low

3.

High Rate of Surgical Success in Complex NSCLC With Neoadjuvant Chemoimmunotherapy

4.

New protein target discovered for childhood medulloblastomas

5.

CAR T-Cell Therapy for Kidney Cancer Builds on Efficacy Record

1.

Late Effects of Immunotherapy in Chronic Melanoma Survivorship with Repurposed Drugs

2.

Public Health Through Cancer Survivorship Infrastructure at the Community Level

3.

Symptoms and Causes of Phlegmasia Cerulea Dolens: A Comprehensive Guide 

4.

Coagulation Factor Consumption During Severe Inflammation: Mechanisms, Clinical Implications, and Advances

5.

Understanding Iron Saturation Levels in Your Blood 

1.

International Cancer Conference

2.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

3.

International Cancer Conference

4.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

Daratumumab, Lenalidomide, and Dexamethasone (DRd) Versus Lenalidomide and Dexamethasone (Rd) in MRD Negativity

2.

An In-Depth Look At The Signs And Symptoms Of Lymphoma- Further Discussion

3.

Immunotherapy: A New Era in Cancer Treatment

4.

Current Scenario of Cancer- An Overview of The Incidence of Cancer in Men

5.

Diagnosis and Management in Hematology

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot